Ventria BioSciences

In 2002, Ventria Bioscience published two papers describing the expression of human proteins in rice grains [74,75]. Lysozyme was expressed under the control of the glutelin 1 promoter, leader and signal peptide, and an expression level of 0.6% dry weight (equivalent to 45% of soluble proteins) was achieved [74]. As was the case for... 

California-based Ventria Bioscience (Sacramento) is at the stage of field trials of transgenic rice plants expressing recombinant lactoferrin and lysozyme in rice seed (see Part IV, Chapter 8). It is worth mentioning, that these products might reach market later than planned considering difficulties with obtaining the necessary field trial permits [39-41]. 

Jacobs, P., Ventria Biosciences, http // www.checkbiotech.org/root/index.cfm fuseac-tion=search search=ventria doc id= 7582 start=l fullsearch=0, 2004(16 April). 

The 1990s and the beginning of the twenty-first century mark a new era of transgenic biopharmaceutical production in plant and animal cells. Researchers all over the world explore various ways to produce biopharmaceuticals in large volumes at a low cost. Scientists at Ventria Bioscience have developed a protein expression system, ExpressTec, which expresses recombinant proteins, enzymes and sec-... 

In order to elevate lignan concentrations in rice endosperm, Ventria Bioscience and... 

---